Smartaging.com will help you age smarter, better and more comfortably by connecting you with the home health and home medical equipment, nutritional products and health monitoring tools you or a loved one need.
Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.
A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.
